Is Insulin a Hotter Product Than Apple's IPad?

REPLAY VIDEO
Your next video will start in
Pause

Recommended Videos

  • Info

  • Comments

April 27 (Bloomberg) -- Novo Nordisk A/S Chief Financial Officer Jesper Brandgaard talks about first-quarter profit. Matthew Weston, a pharmaceutical analyst at Credit Suisse, says "arguably the global diabetes epidemic offers better growth potential versus tech innovation." (Source: Bloomberg)

Advertisement

BTV Channel Finder

Channel_finder_loader

ZIP is required for U.S. locations

Bloomberg Television in   change